Advanced search
Publication Cover
Acta Orthopaedica Volume 85, 2014 - Issue 1
Journal homepage
1,598
Views
38
CrossRef citations to date
0
Altmetric
Register studies, hip and knee

Cancer incidence and cause-specific mortality in patients with metal-on-metal hip replacements in Finland

A population-based study with a mean follow-up of 4.6 (1–11) years

Keijo T MäkeläDepartment of Orthopaedics and Traumatology, Surgical Hospital, Turku University Hospital, TurkuCorrespondence[email protected]
,
Tuomo VisuriHjelt Institute, Helsinki University,Helsinki
,
Pekka PulkkinenHjelt Institute, Helsinki University,Helsinki
,
Antti EskelinenCoxa Hospital for Joint Replacement, Tampere
,
Ville RemesDepartment of Orthopaedics and Traumatology, Peijas Hospital, Helsinki University Central Hospital, Helsinki
,
Petri VirolainenDepartment of Orthopaedics and Traumatology, Surgical Hospital, Turku University Hospital, Turku
,
Mika JunnilaDepartment of Orthopaedics and Traumatology, Surgical Hospital, Turku University Hospital, Turku
&
Eero PukkalaSchool of Health Sciences, University of Tampere, Tampere and the Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland.
 show all
Pages 32-38 | Received 24 Jul 2013, Accepted 11 Nov 2013, Published online: 07 Jan 2014

  • Australian Orthopaedic Association. National Joint Replacement Registry (AOANJRR). Annual Report 2010.
  • Bonassi S, Hagmar L, Strömberg U, Montagud AH, Tinnerberg H, Forni A, et al. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res 2000; 60: 1619–25.
  • Brewster DH, Stockton DL, Reekie A, Ashcroft GP, Howie CR, Porter DE, Black RJ. Risk of cancer following primary total hip replacement or primary resurfacing arthroplasty of the hip: a retrospective cohort study in Scotland. Br J Cancer 2013; 108 (9): 1883–90. doi: 10.1038/bjc.2013.129.
  • Case CP, Langkamer VG, Howell RT, Webb J, Standen G, Palmer M, et al. Preliminary observations on possible premalignant changes in bone marrow adjacent to worn total hip arthroplasty implants. Clin Orthop (Suppl) 1996; (329): 269–79.
  • Cohen D. How safe are metal-on-metal hip implants? BMJ 2012; 344: e1410.
  • Daley B, Doherty AT, Fairman B, Case CP. Wear debris from hip or knee replacements causes chromosomal damage in human cells in tissue culture. J Bone Joint Surg (Br) 2004; 86: 598–606.
  • Lie SA, Engesaeter LB, Havelin LI, Furnes O, Vollset SE. Mortality after total hip replacement: 0-10-year follow up of 39,543 patients in the Norwegian Arthroplasty Register. Acta Orthop Scand 2000; 71: 19–27.
  • Mao X, Wong AA, Crawford RW. Cobalt toxicity – an emerging clinical problem in patients with metal-on-metal hip Prohtheses? Med J Aust 2011; 194: 649–51.
  • McMinn D JW, Snell K IE, Daniel J, Treacy R BC, Pynsent PB, Riley RD. Mortality and implant revision rates of hip arthroplasty in patients with osteoarthritis: registry based cohort study. BMJ 2012; 344: e3319 doi: 10.1136/bmj.e3319
  • Mäkelä KT, Visuri T, Pulkkinen P, Eskelinen A, Remes V, Virolainen P, Junnila M, Pukkala E. Risk of cancer with metal-on-metal hip replacements: population based study. BMJ 2012; 345: e4646 doi: 10.1136/bmj.e4646
  • National Joint Registry for England and Wales (NJR England-Wales). 8th Annual Report 2011.
  • Nyren O, McLaughlin JK, Gridley G, Ekbom A, Johnell OJ, Fraumeni JF, et al. Cancer risk after hip replacement with metal implants: a population-based cohort study in Sweden. J Natl Cancer Inst 1995; 87 (1): 28–33.
  • Oldenburg M, Wegner R, Baur X. Severe cobalt intoxication due to prosthesis wear in repeated total hip arthroplasty. J Arthroplasty 2009; 24: e15–e20.
  • Olsen JO, McLaughlin JK, Nyren O, Mellamkjaer L, Lipworth L, Blot WJ, et al. Hip and knee implantations among patients with osteoarthritis and risk of cancer: a record-linkage study from Denmark. Int J Cancer 1999; 81: 719–22.
  • Onega T, Baron J, MacKenzie T. Cancer after total joint arthroplasty: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15: 1532–7.
  • Ramiah RD, Ashmore AM, Whitley E, Bannister GC. Ten-year life expectancy after primary total hip replacement. J Bone Joint Surg (Br) 2007; 89: 1299–302.
  • Rizzetti MC, Liberini P, Zarattini G, Catalani S, Pazzaglia U, Apostoli P, Padovani A. Loss of sight and sound. Could it be the hip? Lancet 2009; 21: 373(9668): 1052. doi: 10.1016/S0140-6736(09)60490-6
  • Seppänen M, Mäkelä K, Virolainen P, Remes V, Pulkkinen P, Eskelinen A. Hip resurfacing arthroplasty–short term survivorship of 4,401 hip from the Finnish Arthroplasty Register. Acta Orthop 2012; 83: 207–13.
  • Smith AJ, Dieppe P, Porter M, Blom AW. Risk of cancer in first seven years after metal-on-metal hip replacement compared with other bearings and general population: linkage study between the National Joint Registry of England and Wales and hospital episode statistics. BMJ 2012; 344: e2383 doi: 10.1136/bmj.e2383
  • Sotos JG, Tower SS. Systemic disease after hip replacement: aeromedical implications of arthroprosthetic cobaltism. Aviat Space Environ Med 2013; 84: 242–5.
  • Statistics Finland. Causes of death. Health 1999; 3: 18–21.
  • Steens W, von Foerster G, Katzer A. Severe cobalt poisoning with loss of sight after ceramic-metal pairing in a hip-a case report. Acta Orthop 2006; 77: 830–2.
  • Stephensen S, Swartz Lausten G, Thomsen HS, Bjerregaard B. Liposarcoma in association with total hip replacement. Int Orthop 1999; 23: 187–9.
  • Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994; 33: 365–9.
  • Tower SS. Arthroprosthetic cobaltism: neurological and cardiac manifestations in two patients with metal-on-metal Arthroplasty. A case report. J Bone Joint Surg (Am) 2010; 92: 2847–51.
  • Tower SS. Arthroprosthetic cobaltism associated with metal on metal hip implants. BMJ 2012; 344: e430 doi: 10.1136/bmj.e430
  • Visuri T, Pulkkinen P, Turula KB, Paavolainen P, Koskenvuo M. Life expectancy after hip arthroplasty. Case-control study of 1018 cases of primary arthrosis. Acta Orthop Scand 1994; 65: 9–11.
  • Visuri T, Pukkala E, Paavolainen P, Pulkkinen P, Riska EB. Cancer risk after metal on metal and polyethylene on metal total hip arthroplasty. Clin Orthop (Suppl) 1996; (329): S280–9.
  • Visuri T, Pukkala E, Pulkkinen P, Paavolainen P. Decreased cancer risk in patients who have been operated on with total hip and knee arthroplasty for primary osteoarthosis. Acta Orthop Scand 2003; 74: 351–60.
  • Visuri T, Pulkkinen P, Paavolainen P. Malignant tumors at the site of total hip prosthesis. Analytic review of 46 cases. J Arthroplasty 2006; 21: 311–23.
  • Visuri T, Pulkkinen P, Paavolainen P, Pukkala E. Cancer risk is not increased after conventional hip arthroplasty. a natiowide study from the Finnish Arthroplasty Register with follow-up of 24,636 patients for a mean of 13 years. Acta Orthop 2010a; 81: 77–81.
  • Visuri T, Borg H, Pulkkinen P, Paavolainen P, Pukkala E. A retrospective comparative study of mortality and causes of death among patients with metal-on-metal and metal-on-polyethylene total hip prostheses in primary osteoarthritis after a long-term follow-up. BMC Muskuloskel Dis 2010b; 11: 78.
  • Zyviel MG, Brandt JM, Overgaard CB, Cheung AC, Turgeon TR, Syed KA. Fatal cardiomyopathy after revision total hip replacement for fracture of a ceramic liner. Bone Joint J 2013; 95: 31–7.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.